Warning letter
Washington Hospital Center: warning letter of Oct 4, 2007
FDA warning letter UCM076527 · Baltimore District Office
Key facts
| Reference number | UCM076527 |
|---|---|
| Company | Washington Hospital Center |
| Subject | CGMP for Blood & Blood Components/Adulterated |
| Issue date | Oct 4, 2007 |
| Posted date | Oct 4, 2007 |
| Issuing office | Baltimore District Office |
| Product type | Unknown |
| CFR sections cited | 606.170(a), 606.100(c), 606, 606.100(b) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: